Cibc Asset Management Inc Spring Works Therapeutics, Inc. Transaction History

Cibc Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$53.3 - $75.84 $10.5 Million - $14.9 Million	-196,912 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$62.66 - $88.26 $9,524 - $13,415	152 Added 0.08%	196,912 $12.5 Million
Q2 2021 Aug 16, 2021	BUY	$67.45 - $85.63 $6.09 Million - $7.73 Million	90,257 Added 84.75%	196,760 $16.2 Million
Q1 2021 May 14, 2021	SELL	$65.1 - $93.59 $3.22 Million - $4.63 Million	-49,480 Reduced 31.72%	106,503 $7.84 Million
Q4 2020 Feb 03, 2021	BUY	$48.36 - $77.92 $46,715 - $75,270	966 Added 0.62%	155,983 $11.3 Million
Q3 2020 Nov 05, 2020	BUY	$36.14 - $51.99 $1.08 Million - $1.55 Million	29,856 Added 23.85%	155,017 $7.39 Million
Q2 2020 Jul 28, 2020	BUY	$22.98 - $48.57 $319,307 - $674,880	13,895 Added 12.49%	125,161 $5.26 Million
Q1 2020 Apr 30, 2020	BUY	$20.44 - $41.21 $2.27 Million - $4.59 Million	111,266 New	111,266 $3 Million

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.43B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cibc Asset Management Inc with notifications on news.